Cargando…

Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement

BACKGROUND: Patient registry data serves an increasing role in drug safety and comparative effectiveness research, but registry databases often do not contain confounder information measured at the same time that treatments begin. This study evaluated a set of approaches for estimating confounder va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solomon, Daniel H., Shadick, Nancy A., Weinblatt, Michael E., Zak, Agnes, Frits, Michelle, Franklin, Jessica M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470201/ https://www.ncbi.nlm.nih.gov/pubmed/28610614 http://dx.doi.org/10.1186/s13075-017-1330-0

Ejemplares similares

Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries
por: Solomon, Daniel H., et al.
Publicado: (2017)

Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry
por: Shadick, Nancy, et al.
Publicado: (2023)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
por: Lee, Yvonne C, et al.
Publicado: (2011)

Validity of the Nurses’ health study physical activity questionnaire in estimating physical activity in adults with rheumatoid arthritis
por: Quinn, Thomas, et al.
Publicado: (2017)

Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
por: Felson, David, et al.
Publicado: (2022)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach
por: Feldman, Candace H., et al.
Publicado: (2019)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort
por: Ahmad, Harris A., et al.
Publicado: (2018)

An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score
por: Desai, Rishi J, et al.
Publicado: (2015)

Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study
por: Alemao, Evo, et al.
Publicado: (2020)

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia
por: Lee, Yvonne C., et al.
Publicado: (2016)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Incidence and Predictors of Dyspnea on Exertion in a Prospective Cohort of Patients With Rheumatoid Arthritis
por: Sparks, Jeffrey A., et al.
Publicado: (2019)

The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28
por: Sato, Masayo, et al.
Publicado: (2006)

Data‐Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women’s Rheumatoid Arthritis Sequential Study Registry
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data
por: Alemao, Evo, et al.
Publicado: (2016)

The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity
por: Zhuo, Joe, et al.
Publicado: (2022)

The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study
por: Shadick, Nancy A., et al.
Publicado: (2019)

Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
por: Das, Priyam, et al.
Publicado: (2023)

PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis
por: Chang, Hui-Hsin, et al.
Publicado: (2012)

Automatic Prediction of Rheumatoid Arthritis Disease Activity from the Electronic Medical Records
por: Lin, Chen, et al.
Publicado: (2013)

Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis
por: Ercan, Altan, et al.
Publicado: (2012)

Satisfaction With a Virtual Learning Collaborative Aimed at Implementing Treat-to-Target in Rheumatoid Arthritis
por: Ellrodt, Jack, et al.
Publicado: (2022)

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
por: Centola, Michael, et al.
Publicado: (2013)

Methotrexate: who would have predicted its importance in rheumatoid arthritis?
por: Weinblatt, Michael E.
Publicado: (2018)

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
por: Curtis, Jeffrey R, et al.
Publicado: (2012)

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
por: Harrold, Leslie R., et al.
Publicado: (2016)

Validation of rheumatoid arthritis diagnoses in health care utilization data
por: Kim, Seo Young, et al.
Publicado: (2011)

Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry
por: Olsen, Inge C, et al.
Publicado: (2019)

Rheumatoid Nodule Formation in the Kidney: A Diagnosis of Exclusion and a Rare Manifestation of Rheumatoid Arthritis Involving the Kidney
por: Sekulic, Miroslav, et al.
Publicado: (2019)

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2013)

Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis
por: Michaud, Kaleb, et al.
Publicado: (2015)

Malignancy validation in a United States registry of rheumatoid arthritis patients
por: Fisher, Mark C, et al.
Publicado: (2012)

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
por: Degboé, Yannick, et al.
Publicado: (2020)

Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients
por: Jiang, Nan, et al.
Publicado: (2022)

Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis
por: Taylor, Peter C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n9rn8dqlk99b5cdc6mial5apjn